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Heart failure (HF) is a global public health epidemic and burden which is associated with 
increased morbidity and mortality.(1) The economic burden of HF is also substantial; it has 
been reported that HF contributes to about $31 billion in annual healthcare expenditure in 
the USA alone.(2) With the aging of the population and improvements in the treatment of 
cardiovascular diseases (CVDs), the impact of HF is expected to increase proportionately.(3) 
In the USA alone, it has been projected that by 2030, 8 million people will be affected by 
HF.(4)  
 
In addition to other factors, there is a wealth of increasing evidence implicating lifestyle 
factors such as low physical inactivity, poor cardiorespiratory fitness (CRF), and obesity as 
established risk factors for HF (Table).(5-14) It is well known that higher PA levels are 
associated with improved health outcomes and better quality of life. CRF is an index of 
habitual PA levels and is considered the gold standard for aerobic capacity. Several well-
designed large-scale epidemiological studies have reported strong, inverse, and graded 
independent associations of CRF with the risk of HF (Table).(8, 11) Similarly, obesity as 
measured by body mass index (BMI) is related to an increased risk of HF; BMI as a 
continuous variable is also associated with higher HF risk (Table).(5) Other obesity-
associated parameters such as waist circumference (WC), waist-to-hip ratio (WHR), body 
weight, and body fat percentage are also associated with HF risk.(5, 15) There is an inverse 
relationship between CRF and obesity(16) and given that both low CRF and increased 
adiposity are each associated with an increased risk of HF, the pathways through which low 
CRF and obesity might increase the risk of HF are not well understood. The majority of 
previous studies on higher BMI, other obesity parameters, and HF risk did not account for 
differences in CRF levels. It has been suggested that a potential mechanism by which 
obesity parameters such as BMI, WC, and body fat percentage might contribute to the 
development of HF, is through increased ventricular-arterial stiffness.(17) Recent evidence 
suggests that CRF may mediate the risk of HF associated with BMI and high CRF may 




factor for HF, there are findings of a “surprising” relationship between BMI and outcomes in 
HF patients. In patients with already established HF, accumulating evidence suggests that 
overweight and obese (higher BMI) individuals have substantially improved survival 
compared to those with normal BMI, a concept which has been termed “reverse 
epidemiology” or “obesity paradox”.(19) Several mechanisms have been proposed to explain 
the HF obesity paradox and these include HF therapy being more effective in obese 
patients(20) and another is the role of CRF; it has been reported that CRF might mitigate or 
negate the “obesity paradox”.(19, 21) A higher WHR has also been demonstrated to 
challenge the “obesity paradox”.(22) Indeed, the interplay between obesity, CRF, and HF is 
not clearly defined and requires further exploration. 
 
There is little knowledge on the association and interaction between CRF, BMI, and incident 
HF. In this context, Kokkinos and colleagues have conducted an elegant and clinically 
valuable study that aimed to assess the interactive effect of CRF and BMI on the incidence 
of HF in US male veterans.(23) The authors utilized a prospective cohort based on a 
combination of two separate studies with a final sample of 20,254 participants (mean age 58 
years). Exercise capacity (peak METs) was used as a measure of CRF from a maximal 
exercise treadmill test. After a mean follow-up of 14 years, 2,979 HF events were recorded. 
The association between CRF and incident HF was strong, inverse, graded and was 
observed regardless of BMI category (normal weight, overweight, and obese). In addition, 
the association was of similar trend in those <65 and ≥65 years of age, suggesting that CRF 
is protective of HF regardless of age; though the impact of good CRF on HF risk in the 
younger participants was more protective.  Higher BMI or obesity was associated with an 
increased HF; however, the association was null on adjustment for CRF. The authors also 
demonstrated a significant interaction between CRF and BMI levels on HF risk, which 





The strengths of this study include the large sample with adequate numbers of normal 
weight, overweight, and obese participants; the comprehensive panel of blood-based 
markers, comorbidities, and lifestyle characteristics which enabled adequate adjustment for 
potential confounders; and thorough statistical methods which included interaction, dose-
response and several sensitivity analyses.(23)  The limitations comprised (i) the use of an 
observational design which is characterised by residual confounding, regression dilution and 
does not establish causality as acknowledged by the authors; (ii) findings being limited to 
men and therefore not generalisable to women; (iii) lack of data on physical activity patterns 
during follow-up, which could have influenced CRF; (iv) absence of data on HF subtypes; 
and (v) CRF was not assessed using respiratory gas analysis (directly measured oxygen 
uptake, VO2), which is a more objective and quantitative assessment of this measure. In our 
previous studies (Table), we have utilized directly assessed maximal VO2 as the measure of 
CRF, which considers body weight (ml/kg/minute); whereas indirectly assessed CRF 
(treadmill time or exercise test watts) does not.  
 
The current findings of Kokkinos and colleagues are very relevant and welcome, as they 
have several clinical implications for HF prevention.(23) The findings of an independent, 
inverse, and graded association between CRF and HF risk are consistent with previous work 
in this area.(8, 11)  Furthermore, the association persisted despite levels of BMI. The 
association of obesity with HF was attenuated on accounting for CRF level. Overall, these 
findings suggest the association between obesity and HF may be explained by low CRF and 
that high fitness levels could counteract the adverse effects of obesity on HF. It appears 
increased CRF, as an indicator of cardiovascular function, rather than normal weight 
protects against HF risk and as the authors have reported, the findings lend support to the 
concept that fit and overweight or obese is better than unfit and normal weight in HF 
prevention. Given the adverse effect of aging on the incidence of HF, the finding of a 
protective effect of high CRF on HF risk regardless of age is very positive news. In recent 




CVD risk assessment. Cardiopulmonary exercise testing (CPX), which includes the 
assessment of peak VO2 (a measure of CRF) and markers of ventilatory efficiency, is a 
clinically useful tool in HF risk assessment.  
 
CRF is influenced by both genetic as well as environmental factors; approximately half of the 
variation in CRF has been attributed to heritable factors, with the contribution of 
inherited factors to the response of CRF to PA approximating 45-50%.(24) It also depends 
on several factors such as baseline health and fitness status, type, duration, and intensity of 
PA. The level of CRF is also an indicator a chain of multiple physiological processes that 
include: pulmonary ventilation and vascular function, right and left ventricular (LV) function, 
the capacity of the vasculature to accommodate and efficiently transport blood from the heart 
to other organs matching their oxygen requirements, the ability of the muscle cells to use the 
oxygen and other essential nutrients delivered by the blood, and the ability to activate all 
necessary muscle fibres needed for body movement. Left ventricular stroke volume, 
maximal heart rate, and arteriovenous oxygen difference at exercise have essentially 
determined CRF level. Left ventricular function is a key measure of HF and CRF level may 
reflect LV function. As CRF is related to the integration of human body function under 
physiological stress conditions, it can be employed as a very useful indicator of the risk for 
HF, reflecting whole body functional status among patients with existing HF. 
 
We applaud the efforts of Kokkinos and colleagues for throwing more light on the interplay 
between CRF, obesity, and HF. The strong inverse, graded, and consistent observational 
association between CRF and future HF risk suggests a causal association; however, this 
needs to be demonstrated in robust intervention studies. Conclusive evidence from 
intervention studies linking an increased PA level with improved CRF to decreased HF 
incidence is lacking. Mendelian randomisation studies of genetic variants related to CRF 
may provide another route to assess causality. The health benefits associated with regular 




Even the least active behavior which is standing (rather than sitting) is reported to be 
associated with health benefits.(25)  In the absence of further studies, encouraging good 
CRF via regular PA should be promoted extensively via population wide approaches. 
Healthcare providers should also include CRF improvement in treatment of patients with 
chronic diseases and at high risk in clinical practice. Despite the recommendations to 
promote and maintain PA among the general population and individuals at high risk of HF, 
there are still some unanswered questions. The optimal PA or exercise training programme 
for HF prevention is uncertain. Studies are warranted to compare the cardiovascular 
responses to different PA types and their frequencies, intensities and durations in different 
populations such as the elderly and those at elevated HF risk. In the absence of these 
studies, the 2018 Physical Activity Guidelines Advisory Committee Scientific Report 
recommends 150-300 min/week of moderate-intensity or 75-150 min/week of vigorous-
intensity aerobic PA/ exercise for adults, as this is associated with substantial health benefits 
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Table 2. Individual studies and meta-analyses of prospective studies of physical activity, 
cardiorespiratory fitness, and body mass index with heart failure 
Author, year of 
publication 
[reference] 
Name of study 
or source of 
participants 








       
Body mass index 
Aune, 2016 [5] Meta-analysis BMI 647,388 (23) >15,905 incident 
cases 
1.41 (1.34-1.47) Per 5-unit increment in 
BMI 
Aune, 2016 [5] Meta-analysis BMI 215,657 (4) 1,015 deaths 1.25 (0.85-1.87) Per 5-unit increment in 
BMI 
Physical activity 




Meta-analysis PA 165,695 (10) NR 0.72 (0.67-0.79) Most versus least 
physically active 
Cardiorespiratory fitness 
Khan, 2014 [8] KIHD VO2max 1873 152 0.81 (0.69-0.95) Per 1 MET increase 






1,126,899 3,949 0.60 (0.53-0.67) Per extreme quintiles 
Khan, 2017 [10] KIHD VO2max 2,089 522 0.85 (0.78-0.93) Per 1 MET increase 
Myers, 2017 [11] VETS Exercise capacity (in 
METs) 
21,080 1,902 0.25 (0.21-0.31) High-fit versus least-fit 
Kupsky, 2017 [12] Henry Ford 
Health Systems 
Workload (in METs) 66,329 4,652 0.84 (0.82-0.86) Per 1 MET increase 






1,226,623 7,656 1.58 (1.36-1.84) Low versus high CRF 
Khan, 2018 [14] KIHD VO2max 481 46 0.76 (0.59-0.99) Per 1 MET change in 
CRF 
*, for meta-analysis; BMI, body mass index; CCLS, Cooper Center Longitudinal Study; CRF, cardiorespiratory fitness; HF, heart failure; KIHD, 
Kuopio Ischemic Heart Disease; MET, metabolic equivalent; NR, not reported; PA, physical activity; VETS, Veterans Exercise Testing Study; 
VO2max, maximal oxygen uptake 
 
